Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5449]
News [12650]
Articles [175]
Editorials [5]
Conferences [248]
elearning [17]
Bevacizumab extends survival for relapsed and advanced cervical cancer
Dr Krishnansu Sujata Tewari - University of California Irvine Medical Center...
Bevacizumab extends survival for relapsed and advanced cervical cancer ( Dr Krishnansu Sujata Tewari - University of California Irvine Medical Center, USA )
2 Jun 2013
Comment on biennial visual inspection with acetic acid (VIA), or vinegar
Prof Krishnansu Sujata Tewari - University of California Irvine, Orange, USA
Comment on biennial visual inspection with acetic acid (VIA), or vinegar ( Prof Krishnansu Sujata Tewari - University of California Irvine, Orange, USA )
2 Jun 2013
Lapatinib in combination with chemotherapy in breast cancer
Dr J. Randolph Hecht - UCLA Medical Center, Santa Monica, USA
Lapatinib in combination with chemotherapy in breast cancer ( Dr J. Randolph Hecht - UCLA Medical Center, Santa Monica, USA )
2 Jun 2013
Cetuximab superior to bevacizumab for advanced colorectal cancer
Dr Volke Heinemann - University of Munich Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volke Heinemann - University of Munich Munich, Germany )
1 Jun 2013
Improving outcomes of childhood neuroblastoma
Dr Garrett Brodeur - Cancer Center at The Children’s Hospital of Philadelphia...
Improving outcomes of childhood neuroblastoma ( Dr Garrett Brodeur - Cancer Center at The Children’s Hospital of Philadelphia, USA )
1 Jun 2013
Nivolumab produces long-lasting responses in patients with stage IV melanoma
Dr Mario Sznol - Yale Cancer Center, New Haven, USA
Nivolumab produces long-lasting responses in patients with stage IV melanoma ( Dr Mario Sznol - Yale Cancer Center, New Haven, USA )
1 Jun 2013
Delayed relapse of advanced ovarian cancer when treating with pazopanib
Dr Andreas du Bois - Kliniken Essen Mitte, Essen, Germany
Delayed relapse of advanced ovarian cancer when treating with pazopanib ( Dr Andreas du Bois - Kliniken Essen Mitte, Essen, Germany )
1 Jun 2013
Cetuximab superior to bevacizumab for advanced colorectal cancer
Dr Volker Heinemann - University of Munich, Germany
Cetuximab superior to bevacizumab for advanced colorectal cancer ( Dr Volker Heinemann - University of Munich, Germany )
1 Jun 2013
Spouses of patients with HPV-positive oropharyngeal cancer do not have...
Dr Gypsyamber D’Souza - Johns Hopkins Bloomberg School of Public Health...
Spouses of patients with HPV-positive oropharyngeal cancer do not have increased oral HPV infections ( Dr Gypsyamber D’Souza - Johns Hopkins Bloomberg School of Public Health, Baltimore, USA )
1 Jun 2013
Maintenance therapy with multi-targeted drug pazopanib delays relapse of...
Dr Andreas du Bois - Kliniken Essen Mitte, Germany
Maintenance therapy with multi-targeted drug pazopanib delays relapse of advanced ovarian cancer ( Dr Andreas du Bois - Kliniken Essen Mitte, Germany )
1 Jun 2013
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone
Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA
Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )
1 Jun 2013
Profiles of malignant GCTs and potential biomarkers for CNS germ cell tumours
Dr Matthew Murray - Cambridge Cancer Centre, UK
Profiles of malignant GCTs and potential biomarkers for CNS germ cell tumours ( Dr Matthew Murray - Cambridge Cancer Centre, UK )
29 May 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation